Back to CVE records
Medium 4.3Published Sep 29, 2026

CVE-2026-102292coolbeans1212 MateisHomePage-Website users.php cross site scripting

Updated under an hour ago ()

Does this affect you?

It affects coolbeans1212 MateisHomePage-Website. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A flaw has been found in coolbeans1212 MateisHomePage-Website up to ea2a4226deeca27ab1fb9df0552ec76444547811. Affected by this issue is some unknown functionality of the file users.php. This manipulation of the argument Search causes cross site scripting. The attack can be initiated remotely. The exploit has been published and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. Patch name: 6406308df9771d2fd477b56dafe4878dd846df6e. Applying a patch is the recommended action to fix this issue.

CVSS
4.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:O/RC:C
Weakness (CWE)
CWE-79, CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Sep 29, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
coolbeans1212 MateisHomePage-Website
coolbeans1212:mateishomepage-website
ea2a4226deeca27ab1fb9df0552ec76444547811
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit, issue-tracking
  • patch
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.